Eleventh International Conference on Screening for Lung Cancer

        This conference again addressed the two broad missions of these conferences-advancement policy-relevant research on early diagnosis of lung cancer and translation of up-to-date understandings into guidelines for practice based on the accumulated evidence of the International Early Lung Cancer Action Program (I-ELCAP) consortium. Though different entry criteria were used at each participating institution, the use of a common regimen of screening allowed the data on about 27,000 participants with baseline and over 16,000 repeat screenings to be pooled. To date, these screenings have resulted in more than 400 diagnosed cases of lung cancer. Almost all of the diagnosed cases have been screen-rather than interim-diagnosed, over 80% had no identifiable lymph-node involvement, and the median diameter has been 15 mm on the baseline screening and less than 10 mm on repeat screenings. While the 10th Conference had focused on the diagnostic distribution achieved under the screening regimen, the 11th Conference focused on “overdiagnosis,” and on what can now be said to individuals asking their physician for advice about CT screening for lung cancer. The 12th Conference will focus on the overall results of I-ELCAP to date and also on corresponding Japanese results outside of I-ELCAP.
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'


        Subscribe to Clinical Imaging
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect